InsidersTradesSigma
Track the 科拓生物 share price and the full insider trade history of the company, a listed issuer based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 科拓生物 has published 6 insider filings. Market capitalisation: €3.4bn. The latest transaction was filed on 11 December 2025 (Sale). Among the most active insiders: 乔向前. All data is openly available.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€2m
6 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,502 of 29,063 companies
52.1
score / 100
Value29
Quality75
FCF yld-5.0%
Earn yld2.8%
EV/EBITDA25.0x
ROE4.9%
Gross mgn52%
Net mgn26%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 December 2025
Declarations6 total
6 of 6 declarations
Acerca de 科拓生物
科拓生物 es una empresa especializada en el sector de la salud y farmacéutico, centrada en el desarrollo de soluciones biofarmacéuticas. Cotiza en el mercado XSHE.